To confirm the differences in the distribution of MAOA, MAOB, and COMT among male patients with oral cancer (n = 209), pharyngeal cancer (n = 88), OPMD (n = 40), and control (n = 193), we divided the patients into four groups. This evidence concerns the gene COMT and lip and oral cavity carcinoma.